VVOS Vivos Therapeutics, Inc. - Common Stock
$0,61
Prix · Mai 20, 2026
Données fondamentales au Avr 15, 2026
Fourchette 52 semaines
$1–$8
1% of range
Note des analystes
BUY
9 analysts
Objectif de cours
$2
+296% upside
P/E (TTM)
-1.0
ROE
-1368.9%
Marge nette
-121.4%
VVOS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$0.61
Capitalisation Boursière
$19M
P/E (TTM)
-1.0
BPA (TTM)
$-2.07
Revenus (TTM)
$17M
Rendement div.
—
ROE
-1368.9%
Dette/Capitaux propres
-11.4
Fourchette 52 semaines
$1 – $8
VVOS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$17M
2019-12-31
→
2025-12-31
BPA
$-2.07
2022-12-31
→
2025-12-31
Flux de trésorerie libre
$-18M
2020-12-31
→
2025-12-31
Marges
-121.4%
2020-12-31
→
2025-12-31
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
VVOS
Médiane des pairs
P/E (TTM)
-1.0
55.8
P/S (TTM)
1.1
0.2
P/B
-12.7
1.1
EV / EBITDA
-1.8
—
Price / FCF (Cours / FCF)
-1.1
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
VVOS
Médiane des pairs
Gross Margin (Marge Brute)
60.4%
30.6%
Operating Margin (Marge d'exploitation)
-114.1%
—
Net Profit Margin (Marge nette)
-121.4%
-10.1%
ROA
-104.7%
-20.7%
ROE
-1368.9%
-71.5%
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
VVOS
Médiane des pairs
Debt / Equity (Dette / Capitaux propres)
-11.4
179.7
Current Ratio (Ratio de liquidité)
0.2
0.8
Quick Ratio (Ratio de liquidité réduite)
0.2
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
VVOS
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
16.1%
—
Revenue CAGR 3Y (CAGR du chiffre d'affaires 3 ans)
2.9%
—
Revenue CAGR 5Y (CAGR du chiffre d'affaires 5 ans)
5.9%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
VVOS
Médiane des pairs
VVOS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
9 analystes
- Achat fort 2 22,2%
- Achat 5 55,6%
- Conserver 2 22,2%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
3 analystes · 2026-05-16
Médiane
$2.50
← En dessous de tous les objectifs
$0.61
Bas
$1.75
Haut
$3.00
Objectif médian
$2.50
+309,8%
Objectif moyen
$2.42
+296,2%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
-0.03%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 décembre 2025 | $-0.58 | $-0.49 | -0.09% |
| 30 septembre 2025 | $-0.49 | $-0.52 | 0.03% |
| 30 juin 2025 | $-0.55 | $-0.39 | -0.16% |
| 31 mars 2025 | $-0.45 | $-0.41 | -0.04% |
| 31 décembre 2024 | $-0.28 | $-0.40 | 0.12% |
Comparaison avec les pairs Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| VVOS | $19M | -1.0 | 16.1% | -121.4% | -1368.9% | 60.4% |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 17
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17M | $15M | $14M | $16M | $17M | $13M | $11M | |
| Cost of Revenue | $7M | $6M | $6M | $200.0K | $400.0K | $100.0K | · | |
| Gross Profit | $11M | $9M | $8M | $10M | $13M | $10M | $9M | |
| R&D Expense | $100.0K | $100.0K | $100.0K | $200.0K | $200.0K | · | · | |
| SG&A Expense | $28M | $18M | $22M | $29M | $26M | $16M | $16M | |
| Operating Expenses | $30M | $20M | $26M | $35M | $33M | $22M | $19M | |
| Operating Income | $-20M | $-11M | $-17M | $-25M | $-20M | $-12M | $-11M | |
| Interest Expense | $1M | · | · | · | $14.0K | $96.0K | $137.9K | |
| Interest Income | · | · | · | · | $117.0K | $79.0K | $21.1K | |
| Other Non-op | $-1M | $-110.0K | $-212.0K | $-190.0K | $-9.0K | · | · | |
| Pretax Income | $-21M | $-11M | $-14M | $-24M | $-20M | $-12M | $-11M | |
| Net Income | $-21M | $-11M | $-14M | $-24M | $-20M | $-12M | $-11M | |
| EPS (Basic) | $-2.07 | $-2.22 | $-11.14 | $-25.90 | $-0.96 | · | · | |
| EPS (Diluted) | $-2.07 | $-2.22 | $-11.14 | $-25.90 | · | · | · | |
| Shares (Basic) | 10,273,881 | 5,019,886 | 1,219,381 | 920,592 | 21,233,485,000 | · | · | |
| Shares (Diluted) | 10,273,881 | 5,019,886 | 1,219,381 | 920,592 | · | · | · | |
| EBITDA | $-19M | $-11M | $-17M | $-24M | $-20M | $-12M | · |
Bilan 25
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $6M | $2M | $4M | $24M | $18M | $469.4K | |
| Receivables | $2M | $430.0K | $202.0K | $457.0K | $1M | $1M | $871.3K | |
| Prepaid Expense | $774.0K | $783.0K | $616.0K | $1M | $2M | $673.0K | $295.0K | |
| Current Assets | $4M | $7M | $2M | $5M | $27M | $20M | $2M | |
| PP&E (Net) | $4M | $3M | $3M | $3M | $3M | $872.0K | $1M | |
| PP&E (Gross) | $7M | $6M | $6M | $5M | $4M | $2M | $2M | |
| Accum. Depreciation | $3M | $3M | $2M | $2M | $1M | $801.0K | $502.5K | |
| Goodwill | $9M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $4M | $409.0K | $420.0K | $302.0K | $341.0K | $270.0K | $689.2K | |
| Total Assets | $25M | $15M | $11M | $14M | $34M | $25M | $8M | |
| Accounts Payable | $2M | $1M | $2M | $1M | $920.0K | $781.0K | $1M | |
| Accrued Liabilities | $6M | $2M | $2M | $2M | $3M | $2M | $1M | |
| Short-term Debt | $8M | · | · | · | · | · | · | |
| Current Liabilities | $18M | $5M | $7M | $7M | $8M | $8M | $9M | |
| Capital Leases | $4M | $1M | $2M | $2M | · | · | · | |
| Other Non-current Liabilities | $1M | · | · | · | · | · | · | |
| Total Liabilities | $27M | $7M | $10M | $9M | $8M | $8M | $9M | |
| Long-term Debt | $753.0K | · | · | · | $1M | $1M | $4M | |
| Total Debt | $17M | · | · | · | $1M | $1M | · | |
| Common Stock | $1.0K | · | · | · | $2.0K | $2.0K | $1.2K | |
| Paid-in Capital | $124M | $112M | $93M | $84M | $81M | $52M | $20M | |
| Retained Earnings | $-125M | $-104M | $-93M | $-79M | $-56M | $-35M | $-23M | |
| Stockholders' Equity | $-1M | $8M | $411.0K | $5M | $26M | $17M | $-3M | |
| Liabilities + Equity | $25M | $15M | $11M | $14M | $34M | $25M | $8M | |
| Shares Outstanding | 9,286,609 | 5,889,520 | 1,833,877 | 920,592 | 23,012,119 | 18,209,452 | 12,444,165 |
Flux de trésorerie 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $1M | $581.0K | $621.0K | $669.0K | $733.0K | $718.0K | $751.2K | |
| Stock-based Comp | $661.0K | $762.0K | $1M | $2M | $3M | $2M | $2M | |
| Amort. of Intangibles | $600.0K | $100.0K | $100.0K | $100.0K | $300.0K | $400.0K | $424.4K | |
| Other Non-cash | $4M | $-3M | $-90.0K | $1M | · | · | · | |
| Operating Cash Flow | $-15M | $-13M | $-12M | $-20M | $-16M | $-6M | $-5M | |
| CapEx | $2M | $568.0K | $803.0K | $924.0K | $2M | $120.0K | $175.6K | |
| Investing Cash Flow | $-8M | $-568.0K | $-853.0K | $-924.0K | $-3M | $-120.0K | $86.2K | |
| Debt Issued | $11M | · | · | · | · | · | · | |
| Net Debt Issued | $11M | · | · | · | $-25.0K | $-75.0K | · | |
| Stock Issued | $6M | $8M | $4M | · | $28M | $22M | $1M | |
| Net Stock Activity | $6M | $8M | · | · | $28M | $22M | · | |
| Financing Cash Flow | $19M | $18M | $11M | · | $24M | $24M | $4M | |
| Net Change in Cash | $-4M | $5M | $-2M | $-21M | $6M | $18M | $-785.4K | |
| Free Cash Flow | $-18M | $-13M | $-13M | $-21M | $-18M | $-6M | · |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 60.4% | 60.0% | 59.9% | 62.5% | 74.7% | 79.7% | · | |
| Operating Margin | -114.1% | -74.3% | -125.3% | -156.2% | -120.7% | -92.1% | · | |
| Net Margin | -121.4% | -74.1% | -98.4% | -148.8% | -120.2% | -92.3% | · | |
| Pretax Margin | -121.7% | -74.1% | -98.4% | -148.8% | -120.2% | -92.3% | · | |
| EBITDA Margin | -106.5% | -70.5% | -120.8% | -152.0% | -120.7% | -92.1% | · | |
| ROA | -104.7% | -85.6% | -111.1% | -100.6% | -68.8% | -73.3% | · | |
| ROE | -1368.9% | -142.6% | -5944.4% | -325.4% | -70.0% | -160.8% | · |
Liquidité et Solvabilité 5
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | 1.5 | 0.3 | 0.8 | 3.6 | 2.6 | · | |
| Quick Ratio | 0.2 | 1.3 | 0.3 | 0.6 | 3.4 | 2.5 | · | |
| Debt / Equity | -11.4 | · | · | · | 0.0 | 0.1 | · | |
| LT Debt / Equity | -0.3 | · | · | · | · | 0.0 | · | |
| Interest Coverage | -14.2 | · | · | · | -1455.9 | -124.5 | · |
Efficacité 2
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 1.2 | 1.1 | 0.7 | 0.6 | 0.8 | · | |
| Receivables Turnover | 17.3 | 47.6 | 41.9 | 19.3 | 12.8 | 11.4 | · |
Taux de croissance 3
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 16.1% | 8.9% | -13.9% | -5.1% | 29.2% | · | · | |
| Revenue CAGR 3Y | 2.9% | -3.8% | 1.8% | · | · | · | · | |
| Revenue CAGR 5Y | 5.9% | · | · | · | · | · | · |
Valorisation (TTM) 14
| Métrique | Tendance | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17M | $15M | $14M | $16M | $17M | $13M | · | |
| Net Income TTM | $-21M | $-11M | $-14M | $-24M | $-20M | $-12M | · | |
| Market Cap | $19M | $25M | $23M | $231M | $1.29B | $2.69B | · | |
| Enterprise Value | $34M | · | · | · | $1.27B | $2.67B | · | |
| P/E | -1.0 | -1.9 | -1.1 | -0.4 | · | · | · | |
| P/S | 1.1 | 1.7 | 1.7 | 14.4 | 76.7 | 205.9 | · | |
| P/B | -12.7 | 3.2 | 55.5 | 48.2 | 50.7 | 159.0 | · | |
| P / Tangible Book | · | 5.4 | · | 139.7 | 57.9 | 192.5 | · | |
| P / Cash Flow | -1.2 | -2.0 | -1.9 | -11.8 | -82.3 | -473.6 | · | |
| P / FCF | -1.1 | -1.9 | -1.8 | -11.3 | -71.4 | -463.8 | · | |
| EV / EBITDA | -1.8 | · | · | · | -62.4 | -222.1 | · | |
| EV / FCF | -1.9 | · | · | · | -70.1 | -460.9 | · | |
| EV / Revenue | 1.9 | · | · | · | 75.3 | 204.6 | · | |
| Earnings Yield | -102.0% | -51.7% | -89.5% | -257.7% | · | · | · |
Compte de résultat 16
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4M | $7M | $4M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | |
| Cost of Revenue | · | · | · | · | · | · | · | $100.0K | $5M | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | |
| Gross Profit | $3M | $4M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| R&D Expense | · | · | · | · | · | · | · | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | $-100.0K | $100.0K | $100.0K | $100.0K | |
| SG&A Expense | $9M | $8M | $6M | $5M | $4M | $4M | $4M | $5M | $5M | $5M | $6M | $7M | $6M | $7M | $8M | $8M | |
| Operating Expenses | $9M | $9M | $7M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $7M | $7M | $8M | $8M | $10M | $9M | |
| Operating Income | $-6M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-4M | $-5M | $-5M | $-6M | $-5M | $-7M | $-7M | |
| Interest Expense | $800.0K | $500.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-op | $-635.0K | $-679.0K | $-163.0K | $-4.0K | $-69.0K | $-18.0K | $-22.0K | $-1.0K | $15.0K | $-53.0K | $-225.0K | $51.0K | $-79.0K | $-36.0K | $-37.0K | $-38.0K | |
| Pretax Income | $-7M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-2M | $-6M | $-2M | $-6M | $-5M | $-7M | $-5M | |
| Net Income | $-7M | $-5M | $-5M | $-4M | $-3M | $-3M | $-2M | $-4M | $-4M | $-2M | $-6M | $-2M | $-6M | $-5M | $-7M | $-5M | |
| EPS (Basic) | $-0.58 | $-0.49 | $-0.55 | $-0.45 | $0.41 | $-0.40 | $-0.60 | $-1.63 | $-3.05 | $-1.75 | $-4.62 | $-1.72 | $-18.92 | $-6.40 | $-0.33 | $-0.25 | |
| EPS (Diluted) | $-0.58 | $-0.49 | $-0.55 | $-0.45 | $0.41 | $-0.40 | $-0.60 | $-1.63 | $-3.05 | $-1.75 | $-4.62 | $-1.72 | $-18.92 | $-6.40 | $-0.33 | $-0.25 | |
| Shares (Basic) | -18,372,199 | 10,963,590 | 9,087,202 | 8,595,288 | -7,131,951 | 6,615,320 | 3,228,363 | 2,308,154 | -2,165,804 | 1,197,258 | 1,197,258 | 990,669 | -42,395,824 | 849,446 | 21,233,485 | 21,233,485 | |
| Shares (Diluted) | -18,372,199 | 10,963,590 | 9,087,202 | 8,595,288 | -7,131,951 | 6,615,320 | 3,228,363 | 2,308,154 | -2,165,804 | 1,197,258 | 1,197,258 | 990,669 | 71,146 | 849,446 | 21,233,485 | · | |
| EBITDA | · | $-5M | $-5M | $-4M | · | $-3M | $-2M | $-4M | · | $-3M | $-5M | $-5M | · | $-5M | $-7M | $-7M |
Bilan 25
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $3M | $4M | $2M | $6M | $6M | $7M | $3M | $2M | $988.0K | $4M | $7M | $4M | $7M | $13M | $18M | |
| Receivables | $2M | $2M | $2M | $718.0K | $430.0K | $454.0K | $395.0K | $525.0K | $202.0K | $228.0K | $327.0K | $321.0K | $457.0K | $866.0K | $791.0K | $1M | |
| Prepaid Expense | $774.0K | $565.0K | $695.0K | $547.0K | $783.0K | $634.0K | $554.0K | $475.0K | $616.0K | $769.0K | $1M | $1M | $1M | $2M | $2M | $2M | |
| Current Assets | $4M | $6M | $7M | $4M | $7M | $7M | $8M | $4M | $2M | $2M | $5M | $9M | $5M | $10M | $16M | $22M | |
| PP&E (Net) | $4M | $6M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| PP&E (Gross) | $7M | $9M | $8M | $6M | $6M | $6M | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | |
| Accum. Depreciation | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | |
| Goodwill | $9M | $8M | $8M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Intangibles | $4M | $2M | $2M | $358.0K | $409.0K | $383.0K | $395.0K | $408.0K | $420.0K | $433.0K | $445.0K | $458.0K | $302.0K | $312.0K | $322.0K | $331.0K | |
| Total Assets | $25M | $26M | $26M | $11M | $15M | $15M | $16M | $12M | $11M | $10M | $14M | $17M | $14M | $18M | $24M | $30M | |
| Accounts Payable | $2M | $2M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $644.0K | $1M | $877.0K | |
| Accrued Liabilities | $6M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Short-term Debt | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Liabilities | $18M | $7M | $6M | $5M | $5M | $5M | $7M | $8M | $7M | $7M | $8M | $8M | $7M | $6M | $7M | $6M | |
| Capital Leases | $4M | $3M | $3M | $932.0K | $1M | $1M | $1M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | |
| Other Non-current Liabilities | $1M | $1M | $1M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $27M | $23M | $21M | $7M | $7M | $8M | $9M | $11M | $10M | $10M | $12M | $10M | $9M | $9M | $10M | $9M | |
| Long-term Debt | $753.0K | $9M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Total Debt | · | $17M | $15M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Common Stock | $1.0K | $1.0K | · | · | · | · | · | · | · | $3.0K | $3.0K | $3.0K | · | $2.0K | $2.0K | $2.0K | |
| Paid-in Capital | $124M | $121M | $118M | $112M | $112M | $109M | $105M | $97M | $93M | $89M | $89M | $88M | $84M | $83M | $83M | $82M | |
| Retained Earnings | $-125M | $-118M | $-113M | $-108M | $-104M | $-101M | $-99M | $-97M | $-93M | $-89M | $-87M | $-81M | $-79M | $-73M | $-68M | $-61M | |
| Stockholders' Equity | $-1M | $3M | $5M | $4M | $8M | $8M | $6M | $582.0K | $411.0K | $46.0K | $2M | $7M | $5M | $10M | $15M | $21M | |
| Liabilities + Equity | $25M | $26M | $26M | $11M | $15M | $15M | $16M | $12M | $11M | $10M | $14M | $17M | $14M | $18M | $24M | $30M | |
| Shares Outstanding | 9,286,609 | 8,266,877 | 7,324,807 | 5,889,520 | 5,889,520 | 4,765,300 | 3,401,488 | 2,731,270 | 1,833,877 | 1,197,258 | 29,928,786 | 29,928,786 | 920,592 | 23,012,119 | 23,012,119 | 23,012,119 |
Flux de trésorerie 12
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $442.0K | $384.0K | $306.0K | $177.0K | $144.0K | $146.0K | $145.0K | $146.0K | $149.0K | $149.0K | $148.0K | $175.0K | $169.0K | $176.0K | $283.0K | $41.0K | |
| Stock-based Comp | $47.0K | $55.0K | $242.0K | $317.0K | $57.0K | $142.0K | $270.0K | $293.0K | $152.0K | $189.0K | $459.0K | $306.0K | $775.0K | $350.0K | $662.0K | $609.0K | |
| Amort. of Intangibles | $300.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | $-200.0K | $100.0K | $100.0K | $100.0K | |
| Other Non-cash | · | · | · | $-426.0K | · | · | · | $808.0K | · | · | · | $-2M | · | · | · | $-1M | |
| Operating Cash Flow | $-4M | $-4M | $-3M | $-4M | $-3M | $-4M | $-3M | $-3M | $-3M | $-3M | $-3M | $-4M | $-3M | $-6M | $-5M | $-6M | |
| CapEx | $2M | $-83.0K | $771.0K | $122.0K | $165.0K | $192.0K | $60.0K | $151.0K | $165.0K | $154.0K | $245.0K | $239.0K | $200.0K | $100.0K | $504.0K | $120.0K | |
| Investing Cash Flow | $-2M | $83.0K | $-6M | $-122.0K | $-165.0K | $-192.0K | $-60.0K | $-151.0K | $-165.0K | $-154.0K | $-245.0K | $-289.0K | $-200.0K | $-100.0K | $-504.0K | $-120.0K | |
| Debt Issued | $1M | $-417.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $3M | $2M | · | · | $4M | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $3M | · | · | $3M | $4M | $7M | $4M | $4M | $0 | $0 | $7M | · | · | · | · | |
| Net Change in Cash | $-1M | $-1M | $2M | $-4M | $-51.0K | $-592.0K | $4M | $968.0K | $655.0K | $-3M | $-3M | $4M | $-3M | $-6M | $-5M | $-6M | |
| Free Cash Flow | · | · | · | $-4M | · | · | · | $-3M | · | · | · | $-4M | · | · | · | $-6M |
Rentabilité 7
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | 58.0% | 55.2% | 50.0% | · | 60.5% | 65.4% | 56.6% | · | 57.5% | 61.8% | 60.6% | · | 58.8% | 61.9% | 70.0% | |
| Operating Margin | · | -69.8% | -127.4% | -129.9% | · | -68.5% | -47.8% | -110.7% | · | -105.7% | -133.1% | -129.8% | · | -127.3% | -166.4% | -182.2% | |
| Net Margin | · | -79.6% | -131.2% | -128.1% | · | -67.8% | -47.6% | -110.1% | · | -63.4% | -162.8% | -44.1% | · | -128.0% | · | -146.3% | |
| Pretax Margin | · | -79.6% | -131.2% | -128.1% | · | -67.8% | -47.6% | -110.1% | · | · | · | · | · | -128.0% | -167.1% | -146.3% | |
| EBITDA Margin | · | -69.8% | -127.4% | -124.0% | · | -68.5% | -47.8% | -106.4% | · | -105.7% | -133.1% | -125.2% | · | -127.3% | -166.4% | -181.1% | |
| ROA | · | -26.4% | -23.9% | -33.5% | · | -20.4% | -13.0% | -26.0% | · | -14.6% | -29.0% | -7.3% | · | -18.3% | · | -20.7% | |
| ROE | · | -105.9% | -91.7% | -154.9% | · | -67.8% | -45.7% | -99.4% | · | -42.3% | -65.2% | -12.2% | · | -25.7% | · | -30.1% |
Liquidité et Solvabilité 5
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.8 | 1.0 | 0.8 | · | 1.4 | 1.2 | 0.4 | · | 0.3 | 0.6 | 1.1 | · | 1.6 | 2.3 | 3.4 | |
| Quick Ratio | · | 0.7 | 0.9 | 0.7 | · | 1.3 | 1.1 | 0.4 | · | 0.2 | 0.5 | 0.9 | · | 1.3 | 2.0 | 3.0 | |
| Debt / Equity | · | 6.6 | 3.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | · | 3.3 | 1.7 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | -9.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Efficacité 2
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.3 | 0.2 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | |
| Receivables Turnover | · | 5.2 | 3.8 | 4.9 | · | 11.3 | 11.2 | 8.1 | · | 6.0 | 6.1 | 5.8 | · | 1.8 | 2.0 | 2.7 |
Valorisation (TTM) 13
| Métrique | Tendance | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $17M | $15M | $14M | · | $15M | $14M | $14M | · | $15M | $16M | $16M | · | $17M | $17M | $16M | |
| Net Income TTM | · | $-17M | $-13M | $-12M | · | $-10M | $-13M | $-13M | · | $-15M | $-20M | $-19M | · | $-23M | $-22M | $-18M | |
| Market Cap | · | $26M | $23M | $17M | · | $12M | $8M | $13M | · | $6M | $382M | $255M | · | $374M | $742M | $1.54B | |
| Enterprise Value | · | $39M | $34M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | · | -1.6 | -1.6 | -0.9 | · | -0.6 | -0.3 | -0.5 | · | -0.3 | -1.0 | -1.0 | · | · | · | · | |
| P/S | · | 1.5 | 1.6 | 1.2 | · | 0.8 | 0.5 | 0.9 | · | 0.4 | 24.3 | 16.0 | · | 22.5 | 44.0 | 95.6 | |
| P/B | · | 10.1 | 5.1 | 3.8 | · | 1.6 | 1.2 | 22.7 | · | 124.9 | 181.2 | 36.5 | · | 37.9 | 50.0 | 73.3 | |
| P / Tangible Book | · | · | · | 13.9 | · | 2.8 | 2.4 | · | · | · | · | 69.1 | · | 55.8 | 63.6 | 86.3 | |
| P / Cash Flow | · | · | · | -4.4 | · | · | · | -5.2 | · | · | · | -72.1 | · | · | · | -253.5 | |
| P / FCF | · | · | · | -4.3 | · | · | · | -4.9 | · | · | · | -67.5 | · | · | · | -248.6 | |
| EV / EBITDA | · | -8.3 | -7.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | · | 2.2 | 2.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | · | -61.0% | -63.3% | -108.1% | · | -167.8% | -387.4% | -201.2% | · | -301.9% | -102.5% | -102.0% | · | · | · | · |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $17M | $15M | $14M | $16M | $17M |
| Marge Brute % | 60.4% | 60.0% | 59.9% | 62.5% | 74.7% |
| Marge d'exploitation % | -114.1% | -74.3% | -125.3% | -156.2% | -120.7% |
| Résultat net | $-21M | $-11M | $-14M | $-24M | $-20M |
| BPA dilué | $-2.07 | $-2.22 | $-11.14 | $-25.90 | — |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dette / Capitaux propres | -11.4 | — | — | — | 0.0 |
| Ratio de liquidité | 0.2 | 1.5 | 0.3 | 0.8 | 3.6 |
| Ratio de liquidité réduite | 0.2 | 1.3 | 0.3 | 0.6 | 3.4 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-18M | $-13M | $-13M | $-21M | $-18M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.